Study details
Enrolling now
Hyperbaric Oxygen Brain Injury Treatment Trial
Gaylan Rockswold
NCT IDNCT02407028ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
200
Study length
about 11 years
Ages
16–65
Locations
10 sites in CA, FL, IA +7
About this study
This trial is testing different hyperbaric oxygen treatments for people with traumatic brain injury. The goal is to find the best way to use hyperbaric oxygen to improve outcomes in a future trial.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Hyperbaric oxygen (1.5 ATA + NBH)
- 2.Take Hyperbaric oxygen (1.5 ATA, no NBH)
- 3.Take Hyperbaric oxygen (2.0 ATA + NBH)
- +3 more
PhasePhase 2
DrugHyperbaric oxygen (1.5 ATA, no NBH)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
VARIOUS
Endpoints
Secondary: Serious adverse events